Skip to content

SodiUm Burden lowered by Lifestyle Intervention: Self-Management and E-health technology

SodiUm Burden lowered by Lifestyle Intervention: Self-Management and E-health technology - SUBLIME

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40912
Enrollment
150
Registered
2014-04-28
Start date
2014-06-18
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease renal disease

Interventions

Two group meetings with fellow-patients, motivational interviewing, e-coaching, blood pressure monitoring at home and ICT-based self-regulation as add-on to regular care
control patients receive regular care.

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Be 18 years or older. 2. Have chronic kidney disease (CKD stage 1-3, CKD 4 if eGFR is not lower than 25 mL/min/1.73m2, or be a renal transplant recipient.) 3. Have a urinary sodium excretion during at least the last 2 subsequent visits of more than 130 mmol per day, or one last urinary sodium excretion of more than 150 mmol per day. 4. Have a systolic blood pressure higher than 135 mmHg, diastolic blood pressure higher than 85 mmHg or a well-controlled blood pressure by treatment with antihypertensives including RAAS-blockade (ACE-inhibitor or ARB). 5. Sufficient command of the Dutch language. 6. Access and ability to use the internet. 7. Written informed consent.

Exclusion criteria

Exclusion criteria: - eGFR 6 mL/min/1.73m2 per year), not from acute, intermittent origin. - Blood pressure > 170 mmHg systolic or > 100 mmHg diastolic during medical treatment - Blood pressure

Design outcomes

Primary

MeasureTime frame
Primary outcome: sodium intake, assessed from 24h sodium excretion,

Secondary

MeasureTime frame
Secondary outcomes: blood pressure, proteinuria, psychological well-being and costs-efficiency, efficacy.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)